Epidemiology of Sleep-Disordered Breathing in Adults
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
To characterize the natural history and biologic spectrum of sleep disordered breathing (SDB) and other sleep problems and disorders, and test hypotheses regarding the causes and consequences of SDB and other sleep problems and disorders.
| Condition |
|---|
|
Sleep Disorders Cerebrovascular Disorders Cardiovascular Disease Neurologic Disorders Mood Disorders |
| Study Type: | Observational |
| Study Design: | Observational Model: Cohort Time Perspective: Prospective |
| Official Title: | Epidemiology of Sleep-Disordered Breathing in Adults |
- sleep disorders and problems, cardiovascular and cognitive outcomes [ Time Frame: measured at each study visit ] [ Designated as safety issue: No ]Overnight polysomnography is used to assess sleep pathology. Questionnaires are used to assess sleep habits. A variety of clinical and laboratory assessments measure cardiovascular and cognitive outcomes.
- cardiovascular outcomes [ Time Frame: measured at each study visit ] [ Designated as safety issue: No ]A variety of clinical and laboratory assessments measure cardiovascular outcomes.
- cognitive outcomes [ Time Frame: measured at each study visit ] [ Designated as safety issue: No ]A variety of clinical and laboratory assessments measure cognitive outcomes.
- gait and balance [ Time Frame: measured at each study visit ] [ Designated as safety issue: No ]A series of walking tests are conducted.
- mental health outcomes [ Time Frame: evaluated at each study visit ] [ Designated as safety issue: No ]Questionnaires assess mood, depression, and anxiety.
| Enrollment: | 1545 |
| Study Start Date: | April 1999 |
| Estimated Study Completion Date: | April 2014 |
| Estimated Primary Completion Date: | April 2014 (Final data collection date for primary outcome measure) |
BACKGROUND:
Recent research has shown that sleep disordered breathing (SDB) is much more common than previously thought. While it is known that in clinic samples, SDB is associated with hypertension, cardiovascular disease and mortality, little is known about the natural history of this disorder, particularly in the general population, nor about the causal role of known risk factors. The knowledge obtained from the results of this study will help advance the field of sleep disorders medicine. Information about longitudinal effects and causal relationships may be applied to clinical situations, thus reducing the morbidity and mortality associated with this disorder.
DESIGN NARRATIVE:
In this longitudinal study, follow-up polysomnography and other protocols are conducted on an established cohort of men and women (age 30-60 years at the time of initial recruitment in 1989), currently enrolled in the Wisconsin Sleep Cohort Study. The study aims to : 1) describe the natural history of SDB across middle and older age; 2) investigate associations of SDB with early and intermediate markers of cardiovascular dysfunction, damage, and cardiovascular disease; 3) investigate the longitudinal association of SDB in accelerated cognitive decline; 4) investigate the association of SDB and adverse sleep characteristics with age-related risk factors and outcomes.
Eligibility| Ages Eligible for Study: | 30 Years and older |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | Yes |
| Sampling Method: | Probability Sample |
In 1988, employees of 4 Wisconsin state agencies, ages 30-60 years, were surveyed regarding sleep habits and problems by mail. From these data, a sampling frame was constructed and 2884 randomly-selected men and women (of 4896 survey respondents) were invited to participate in the WSC Study. Recruitment for baseline sleep studies occurred from 1989 to 2004.
Inclusion criteria:
- Employee of one of the 4 Wisconsin state agencies
- Age 30-60 in 1988
Exclusion criteria:
- Current pregnancy
- Unstable or decompensated cardiopulmonary disease
- Airway cancer
- Recent upper respiratory surgery
Contacts and Locations| United States, Wisconsin | |
| University of Wisconsin Hospital and Clinics | |
| Madison, Wisconsin, United States, 53705 | |
| Principal Investigator: | Paul E Peppard, PhD | University of Wisconsin, Madison |
More Information
Publications:
| Responsible Party: | University of Wisconsin, Madison |
| ClinicalTrials.gov Identifier: | NCT00005557 History of Changes |
| Other Study ID Numbers: | 2012-0084, R01HL062252 |
| Study First Received: | May 25, 2000 |
| Last Updated: | December 11, 2012 |
| Health Authority: | United States: Federal Government |
Additional relevant MeSH terms:
|
Respiratory Aspiration Cardiovascular Diseases Cerebrovascular Disorders Nervous System Diseases Sleep Apnea Syndromes Sleep Disorders Parasomnias Mood Disorders Respiration Disorders Respiratory Tract Diseases |
Signs and Symptoms, Respiratory Signs and Symptoms Brain Diseases Central Nervous System Diseases Vascular Diseases Apnea Sleep Disorders, Intrinsic Dyssomnias Neurologic Manifestations Mental Disorders |
ClinicalTrials.gov processed this record on May 21, 2013